Biocomputational Prediction Approach Targeting FimH by Natural SGLT2 Inhibitors: A Possible Way to Overcome the Uropathogenic Effect of SGLT2 Inhibitor Drugs

The Food and Drug Administration (FDA) approved a new class of anti-diabetic medication (a sodium–glucose co-transporter 2 (SGLT2) inhibitor) in 2013. However, SGLT2 inhibitor drugs are under evaluation due to their associative side effects, such as urinary tract and genital infection, urinary disco...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Mutaib M. Mashraqi, Navaneet Chaturvedi, Qamre Alam, Saleh Alshamrani, Mosa M. Bahnass, Khurshid Ahmad, Amany I. Alqosaibi, Mashael M. Alnamshan, Syed Sayeed Ahmad, Mirza Masroor Ali Beg, Abha Mishra, Sibhghatulla Shaikh, Syed Mohd Danish Rizvi
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2021-01-01
Serie:	Molecules
Soggetti:	sodium–glucose co-transporters 2 FimH uropathogenic bacteria urinary tract infections diabetes
Accesso online:	https://www.mdpi.com/1420-3049/26/3/582
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!